ClinicalTrials.gg
Status unknownNCT05171504Updated Dec 29, 2021

Lactoferrin and Iron in Seminal Plasma of Varicocele

An observational study in Varicocele, sponsored by Assiut University. Status unknown. Open to male participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2021-12-29.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
75
Ages
20 Years to 50 Years
Sex
Male
01

Study summary

Infertility is defined by World Health Organization (WHO) as a disease of reproductive system characterized by failure to achieve clinical pregnancy even after 12 months or more of regular unprotected sexual intercourse. It affects around 15% of all couples, that is 48.5 million couples worldwide.

Male infertility has emerged as an important cause of infertility worldwide. There are many factors affecting male fertility and research is going on to know impact of various factors on sperm functions.Male infertility affects 30:40% of cases.

Infertility could be due to different aetiologies. Among the possible causes are genetic factors, obstructive disorders (congenital absence of vas deferens), varicocele and testicular dysgenesis. However, some cases of male infertility are idiopathic.

Read the detailed description

Varicocele is considered as the second most common cause of infertility. In the general population, approximately 15% of adult men have varicocele, but in the population of infertile men, the prevalence rises to 40% of cases with primary infertility and 80% in secondary infertility .

Varicocele is characterised by dilated veins of the pampiniform plexus which are responsible for the testicular blood drainage.Varicocele can affect fertility through hypoxia of the testicular tissues, germ cell apoptosis, oxidative stress, reflux of toxic metabolites from the renal/adrenal tissues and hyperthermia of the testis.

Semen analysis is the gold standard diagnostic test for male infertility. Seminal plasma is considered a gold mine for male fertility as it contains molecules from male reproductive glands which play important role in sperm function.

Lactoferrin is an iron-binding globular glycoprotein that act as immunomodulator mainly at mucosal level. In general, lactoferrin plays important role in the regulation of iron absorption, the modulation of immune responses, and has anti-microbial, anti-viral, antioxidant, anticancer, and anti-inflammatory activities.

Lactoferrin is found in various exocrine fluids and blood plasma. It is secreted from the prostate and seminal vesicles in humans. The physiological role of the lactoferrin in the male reproductive tract remains unclear.

Few studies have investigated the effect of lactoferrin on semen quality in humans. A recent study has demonstrated that lactoferrin expression on cells of seminal fluid was associated with worse sperm concentration and morphology, considering it as a possible novel marker of male infertility. Other studies showed that seminal lactoferrin concentrations were raised in patient groups with oligozoospermia and oligoasthenozoospermia.

Iron is an essential trace nutrient that plays an important role in general health and fertility. It is not essentially toxic, but disturbances can appear due to prolonged intake of high doses or dysfunction in the regulatory mechanism.

Iron is one of the trace elements that present in semen.It participates in oxygenation and reduction processes, entering into the composition of many enzymes and metalloprotein compounds. It has been reported that iron can cause an increase in sperm damage.

The toxicity of iron could result from the formation of hydroxyl free radicals. Iron-induced oxidative stress may induce lipid peroxidation, which has been shown to result in deterioration of sperm morphology and motility. So, iron is highly toxic if accumulated in large quantities. Also,the excess or deficiency may lead to defective spermatogenesis and to fertility impairment.

Most of the previous researches on the effect of iron on sperm function have shown increased level of seminal iron in sub-fertile than fertile men. In addition, significant higher concentrations of seminal iron were detected in asthenozoospermic and teratozoospermic groups.

On the contrary, a study has demonstrated that iron level and other trace elements were significantly lower in seminal fluid of asthenozoospermic subjects in comparison with normozoospermic men. In that study, although higher levels of iron were detected in men with normal semen analysis, these higher levels adversely affected sperm motility in this group.

02

Conditions studied

  • Varicocele

Browse trials for

Keywords

  • lactoferrin, iron
03

In context

Varicocele

53 studies on the registry are indexed under Varicocele; 15 are open to participants now.

This study's planned enrollment of 75 is below the median of 119 across 17 observational studies indexed under Varicocele.

Browse Varicocele studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
Male
Sampling method
Non-probability sample

Study population

The participants will be divided in to three equal groups:

Group I: will include 25 patients with varicocele seeking medical advice for infertility.

Group II: will include 25 patients seeking medical advice for infertility due to other causes than varicocele as a control group.

Group III: will include 25 fertile male participants as a control group.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Group I will include infertile patients with varicocele that is diagnosed clinically and by doppler scrotal ultrasonography.
  • Group II will include infertile patients due to other causes than varicocele
  • Group III will include fertile men with history of childbirth within the previous year.

Exclusion criteria

Exclusion Criteria:

The patients will be excluded from the group I in the following conditions:

  1. History or evidence of Genital tract infection.
  2. History or evidence of hormonal/chromosomal abnormalities.
  3. History or evidence of chronic debilitating diseases.
  4. History of hormonal treatment or chemotherapy.
  5. Low semen volume less than 1.5 ml.
  6. Severe oligozoospermia less than 5x10*6 /ml.
  7. Azoospermia.
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
75 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • I , Infertile males with varicocele

    Lactoferrin , iron in seminal plasma and semen analysis from Infertile patients with varicocele

  • II , infertile males due to other causes than varicocele

    Lactoferrin , iron in seminal plasma and semen analysis from infertile patients due to other causes than varicocele

  • III , fertile males

    Lactoferrin , iron in seminal plasma and semen analysis from fertile males with history of childbirth within the previous year

06

What researchers measure

Primary outcomes

  1. Detection of lactoferrin and iron in seminal plasma and their possible relation to fertility status in varicocele

    Correlation of the level of lactoferrin and iron in seminal plasma with semen parameters in infertile patients with varicocele , infertile patients due to other causes than varicocele and fertile men. Evaluation the level of lactoferrin in seminal plasma by using ELISA method and the level of iron in seminal plasma by semiautomated colorimetric method.

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Collodel G, Signorini C, Nerucci F, Gambera L, Iacoponi F, Moretti E. Semen Biochemical Components in Varicocele, Leukocytospermia, and Idiopathic Infertility. Reprod Sci. 2021 Jan;28(1):91-101. doi: 10.1007/s43032-020-00260-0. Epub 2020 Jul 22. PubMed 32696238 ↗
  • Aydemir B, Kiziler AR, Onaran I, Alici B, Ozkara H, Akyolcu MC. Impact of Cu and Fe concentrations on oxidative damage in male infertility. Biol Trace Elem Res. 2006 Sep;112(3):193-203. doi: 10.1385/BTER:112:3:193. PubMed 17057258 ↗
  • Kamal HM, El-Fallah AA, Abdelbaki SA, Khalil MM, Kamal MM, Behiry EG. Association between seminal granulysin and malondialdehyde in infertile men with varicocele and the potential effect of varicocelectomy. Andrologia. 2020 Jul;52(6):e13579. doi: 10.1111/and.13579. Epub 2020 Apr 9. PubMed 32271478 ↗
  • Kasperczyk A, Dobrakowski M, Czuba ZP, Kapka-Skrzypczak L, Kasperczyk S. Influence of iron on sperm motility and selected oxidative stress parameters in fertile males - a pilot study. Ann Agric Environ Med. 2016 Jun 2;23(2):292-6. doi: 10.5604/12321966.1203893. PubMed 27294635 ↗
  • Hao L, Shan Q, Wei J, Ma F, Sun P. Lactoferrin: Major Physiological Functions and Applications. Curr Protein Pept Sci. 2019;20(2):139-144. doi: 10.2174/1389203719666180514150921. PubMed 29756573 ↗
  • Buckett WM, Luckas MJ, Gazvani MR, Aird IA, Lewis-Jones DI. Seminal plasma lactoferrin concentrations in normal and abnormal semen samples. J Androl. 1997 May-Jun;18(3):302-4. PubMed 9203059 ↗
  • Ammar O, Houas Z, Mehdi M. The association between iron, calcium, and oxidative stress in seminal plasma and sperm quality. Environ Sci Pollut Res Int. 2019 May;26(14):14097-14105. doi: 10.1007/s11356-019-04575-7. Epub 2019 Mar 9. PubMed 30852746 ↗
  • Marzec-Wroblewska U, Kaminski P, Lakota P, Szymanski M, Wasilow K, Ludwikowski G, Kuligowska-Prusinska M, Odrowaz-Sypniewska G, Stuczynski T, Michalkiewicz J. Zinc and iron concentration and SOD activity in human semen and seminal plasma. Biol Trace Elem Res. 2011 Oct;143(1):167-77. doi: 10.1007/s12011-010-8868-x. Epub 2010 Oct 6. PubMed 20924714 ↗
  • Kikuchi M, Takao Y, Tokuda N, Ohnami Y, Orino K, Watanabe K. Relationship between seminal plasma lactoferrin and gonadal function in horses. J Vet Med Sci. 2003 Nov;65(11):1273-4. doi: 10.1292/jvms.65.1273. PubMed 14665762 ↗
  • Gill K, Kups M, Harasny P, Machalowski T, Grabowska M, Lukaszuk M, Matuszewski M, Duchnik E, Fraczek M, Kurpisz M, Piasecka M. The Negative Impact of Varicocele on Basic Semen Parameters, Sperm Nuclear DNA Dispersion and Oxidation-Reduction Potential in Semen. Int J Environ Res Public Health. 2021 Jun 2;18(11):5977. doi: 10.3390/ijerph18115977. PubMed 34199549 ↗
  • Hashemi MM, Behnampour N, Nejabat M, Tabandeh A, Ghazi-Moghaddam B, Joshaghani HR. Impact of Seminal Plasma Trace Elements on Human Sperm Motility Parameters. Rom J Intern Med. 2018 Mar 1;56(1):15-20. doi: 10.1515/rjim-2017-0034. PubMed 28865234 ↗
  • Kumar N, Singh NK. "Emerging role of Novel Seminal Plasma Bio-markers in Male Infertility: A Review". Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:170-179. doi: 10.1016/j.ejogrb.2020.08.015. Epub 2020 Aug 24. PubMed 32871440 ↗
  • Omes C, De Amici M, Tomasoni V, Todaro F, Torre C, Nappi RE. Myeloperoxidase and lactoferrin expression in semen fluid: Novel markers of male infertility risk? Immunobiology. 2020 Sep;225(5):151999. doi: 10.1016/j.imbio.2020.151999. Epub 2020 Aug 5. PubMed 32962819 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05171504
Lead sponsor
Assiut University
Responsible party
Marilyn Sameh (Principle investigator, Assiut University) — Principal investigator
First posted
Dec 29, 2021
Start date
Jun 2022 (estimated)
Primary completion
Dec 2022 (estimated)
Completion
Mar 2023 (estimated)
Last update
Dec 29, 2021

Study contacts

Ali M Mahran, Professor
Contact
alimahran74@yahoo.com
+201223971344
Marwa M Mekkawy, Lecturer
Contact
marwamekkawy@yahoo.com
+201004899436

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion